Actively Recruiting
Eluvia DES for the Patients with Femoropopliteal Artery Lesions.
Led by First Affiliated Hospital of Zhejiang University · Updated on 2024-09-27
400
Participants Needed
1
Research Sites
178 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a multicenter, prospective, observational study, aiming to enroll 400 patients with peripheral arterial disease in the femoral-popliteal segment implanted with Eluvia stent. Each patient was followed up for 2 years. The technical success rate, target lesion patency rate, quality of life improvement, cost of Eluvia stent implantation, and other outcomes will be analysed.
CONDITIONS
Official Title
Eluvia DES for the Patients with Femoropopliteal Artery Lesions.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Rutherford Stage 2-5
- At least 90% stenosis or occlusion of the femoropopliteal artery
- Eluvia stents used for target lesions
- Signed informed consent form
You will not qualify if you...
- Life expectancy less than 1 year
- Severe limb infection, gangrene, or major tissue loss beyond the toes
- Reluctance or communication difficulties preventing quality of life assessment
- In-stent restenosis of the femoral popliteal artery
- Acute arterial thrombosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
First Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, China, 310000
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here